CN Patent

CN102078306A — 一种含有重组人血白蛋白的紫杉醇纳米颗粒冷冻干燥制剂

Assigned to WUXI YUANRONG BIOMEDICINE Co Ltd · Expires 2011-06-01 · 15y expired

What this patent protects

本发明公开一种含有重组人血白蛋白的纳米颗粒冷冻干燥粉末制剂，所述制剂由紫杉醇、磷脂、重组人血白蛋白、冻干支持剂和PH调节剂组成，各组分质量百分比如下：紫杉醇0.05-5％、磷脂0.1-50％、重组人血白蛋白1-60％、冻干支持剂1-60％、PH调节剂0.05-10％。本发明获得的纳米颗粒平均粒径小于0.4um，获得的粉末制剂和注射用水、葡萄糖和生理盐水重制形成PH在5.0-7.0之间的可注射水溶液，大大提高了该制剂的产业化价值。

USPTO Abstract

本发明公开一种含有重组人血白蛋白的纳米颗粒冷冻干燥粉末制剂，所述制剂由紫杉醇、磷脂、重组人血白蛋白、冻干支持剂和PH调节剂组成，各组分质量百分比如下：紫杉醇0.05-5％、磷脂0.1-50％、重组人血白蛋白1-60％、冻干支持剂1-60％、PH调节剂0.05-10％。本发明获得的纳米颗粒平均粒径小于0.4um，获得的粉末制剂和注射用水、葡萄糖和生理盐水重制形成PH在5.0-7.0之间的可注射水溶液，大大提高了该制剂的产业化价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN102078306A
Jurisdiction
CN
Classification
—
Expires
2011-06-01
Drug substance claim
No
Drug product claim
No
Assignee
WUXI YUANRONG BIOMEDICINE Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.